Gold Miners’ Q3’18 Fundamentals

By Adam Hamilton – Re-Blogged From Gold Eagle

The major gold miners’ stocks remain mired in universal bearishness, largely left for dead.  They are just wrapping up their third-quarter earnings season, which proved challenging.  Lower gold prices cut deeply into cash flows and profits, and production-growth struggles persisted.  But these elite companies did hold the line on costs, portending soaring earnings as gold recovers.  Their absurdly-cheap stock prices aren’t justified.

Four times a year publicly-traded companies release treasure troves of valuable information in the form of quarterly reports.  Companies trading in the States are required to file 10-Qs with the US Securities and Exchange Commission by 40 calendar days after quarter-ends.  Canadian companies have similar requirements at 45 days.  In other countries with half-year reporting, many companies still partially report quarterly.

Continue reading

Advertisements

At IPCC talks Trump Administration emphasizes scientific “uncertainty” and “value of fossil fuels”… MAGA!

By David Middleton – Re-Blogged From WUWT

From the No Schist Sherlock files of the American Association for the Advancement of Science of America…

Top researchers are huddled with government officials in South Korea this week to confront the scientific consensus that maintaining a safe global climate will require immediate and aggressive action… Continue reading

Germany’s Energiewende Program Exposed as a Catastrophic Failure

By Larry Hamlin – Re-Blogged From WUWT

An audit of the EU’s leading climate alarmism energy policy program concludes that Germany’s Energiewende is a colossal and hugely expensive debacle.

EU climate alarmist champion Germany has its Energiewende program exposed as a catastrophic failure with enormous costs

Continue reading

Antibiotics for Appendicitis? Surgery Often Not Needed

By Associated Press – Re-Blogged From Newsmax Health

When emergency tests showed the telltale right-sided pain in Heather VanDusen’s abdomen was appendicitis, she figured she’d be quickly wheeled into surgery. But doctors offered her the option of antibiotics instead.

A new study from Finland shows her choice is a reasonable alternative for most patients with appendicitis. Five years after treatment with antibiotics, almost two-thirds of patients hadn’t had another attack.

Continue reading

Unaffordable Green Energy: Charity Begs for More Volunteer Knitters, to Help Poor People Survive Winter

By Eric Worrall – Re-Blogged From WUWT

h/t JoNova – According to the charity KOGO, green energy champion Victora, Australia is experiencing unprecedented demand for charity provided warm woolies to help poor people who can no longer afford to heat their homes.

Continue reading

Solar Electricity Installations Look Like a Gravy Train.

[A regular reader from Melbourne, Australia has this analysis of PV Panel home installation costs. BTW, today’s currency conversion rate is 1 USD = 1.36418 AUD. -Bob]

By tonytran2015 – Re-Blogged From Survival Tricks

With electricity price running out of control, anticipated to hit 40c/kWh in the near future, I have to consider investing in a home system of Solar Panels to reduces my expenditure. The good news is there are some Solar Panels on sale at $150 per square meter and my friend can install them for me at a cost of $150 per square meter. So I drew up the following financial analysis for the prospective installation of 1m2 of panel. The results are quite surprising: Solar electricity is not matured enough to be economically competitive. The Green actions by Australian Governments are mostly a gravy train with well connected, greedy people already having First Class seats on it.

Continue reading

States Rush to Rein In Prescription Costs, and Drug Companies Fight Back

By Robert Pear – Re-Blogged From NY Times

States around the country are clamping down on pharmaceutical companies, forcing them to disclose and justify price increases, but the drug manufacturers are fighting back, challenging the state laws as a violation of their constitutional rights.

Even more states are, for the first time, trying to regulate middlemen who play a crucial role by managing drug benefits for employers and insurers, while taking payments from drug companies in return for giving preferential treatment to their drugs.

Image
Twenty-four states have passed 37 bills this year to curb rising prescription drug costs, according to Trish Riley, the executive director of the National Academy for State Health Policy.CreditJulio

Continue reading